Seah, J.-A.; Sridhar, S.; Wood, L.; Blais, N.; North, S.; Rahim, Y.; Ruether, D.; Black, P.; Zlotta, A. R. Neoadjuvant Chemotherapy (NC) Should Be Administered to Fit Patients With Newly Diagnosed, Potentially Resectable Muscle-Invasive Urothelial Cancer (MIUC) of the Bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process. CUAJ 2013, 7, 312-8.